Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade

Immune-checkpoint blockade in front-line or second-line treatment improves survival in advanced non-small cell lung cancer (aNSCLC) when compared with chemotherapy alone. However, easily applicable predictive parameters are necessary to guide immune-checkpoint inhibition in clinical practice. In thi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Med
Huvudupphovsmän: Huemer, Florian, Lang, David, Westphal, Theresa, Gampenrieder, Simon Peter, Hutarew, Georg, Weiss, Lukas, Hackl, Hubert, Lamprecht, Bernd, Rinnerthaler, Gabriel, Greil, Richard
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6678702/
https://ncbi.nlm.nih.gov/pubmed/31295966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8071014
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk